Melanoma Risks and Risk Prediction in Patients with Actinic Keratosis by Adam Smartt | Dec 31, 2021 | Career Development Award, Featured
Therapeutic Resistance to CDK4/6 inhibitors in BRAF-mutant Melanoma by Adam Smartt | Dec 31, 2021 | Career Development Award, Featured
Targeted intervention of melanoma by reprogramming the stromal translatome by Adam Smartt | Dec 31, 2021 | Career Development Award, Donor Directed, Featured
Control of Anti-Tumor Response by the Modulation of Neurotransmitter-Expressing Immune Cells by Adam Smartt | Jul 26, 2021 | Featured, Team Award
Formulation and Preclinical Testing of an HLA-Engineered Neoantigen Vaccine for Melanoma by Adam Smartt | Feb 18, 2021 | Featured, Medical Student Award
Clinical and genetic predictors of skin toxicity in mucosal melanoma treated with immune checkpoint inhibitors by Adam Smartt | Feb 18, 2021 | Featured, Medical Student Award
Recent Comments